Transforming the Cardiac Marker Testing Market in 2025: Rising Cardiovascular Disease Incidence Fuels Growth In Cardiac Marker Testing Market

What Is the Expected Size and Growth Rate of the Cardiac Marker Testing Market?
In recent times, the market size for cardiac marker testing has experienced significant growth. The projections reveal an increase from $6.52 billion in 2024 to $7.19 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.3%. Various factors such as the increase in the elderly population, an escalation in educational campaigns, improved awareness, advancement in healthcare infrastructure and an increase in patient numbers have contributed to this growth during the historic period.

In the coming years, a substantial increase is projected in the cardiac marker testing market size, with a forecasted value of $10.56 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 10.1%. Factors contributing to this acceleration during the prediction span include escalating rates of heart-related disorders, amplified strategic affiliations and partnerships, heightened research and evolution undertakings, beneficial reimbursement policies, and a surge in demand for point-of-care (POC) testing. The forecast period also sees prominent patterns such as improved diagnostic technologies, automated diagnostic devices, sophisticated cardiac marker testing assays, growth in digital health technologies, and the advent of cohesive technologies.

What Factors Are Fueling Growth in the Cardiac Marker Testing Market?
The increasing occurrence of cardiovascular illnesses is projected to spur the cardiac marker testing market's expansion in the future. Cardiovascular diseases (CVDs), which encompass afflictions impacting the heart and blood vessels like coronary artery disease, heart failure and stroke, are seeing a surge in cases. This rise is primarily attributed to unhealthy eating habits, lack of physical activity, tobacco consumption, alcohol abuse, and exposure to air pollutants. To accurately diagnose, evaluate the gravity, and monitor the development or treatment response of heart conditions, cardiac marker testing is necessitated. These tests detect specific biomarkers that are released during myocardial damage or heart injury. As an illustration, the American Heart Association, an established nonprofit organization in the U.S, reported an increase in the age-adjusted death rate from cardiovascular disease to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 when compared to its previous year, in January 2024. In 2021, 20,114 deaths in the U.S. were due to sudden cardiac arrest. Therefore, this escalating prevalence of cardiovascular diseases is driving the growth of the cardiac marker testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp

Which Leading Companies Are Shaping the Growth of the Cardiac Marker Testing Market?
Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

What Are the Major Trends Shaping the Cardiac Marker Testing Market?
Key players in the cardiac marker testing market are prioritizing the development of high-tech products, including cardiac assays, to offer significant and accurate data concerning cardiac health and performance. These cardiac assays are specialized tests constructed to identify biomarkers or other signs in the blood or various specimens to determine cardiac function, diagnose cardiovascular disorders, or estimate the probability of heart-associated conditions. For example, in October 2023, Mindray, a medical device firm based in China, introduced troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay is characterized by extraordinary sensitivity, precision, and reliability, exceeding minimum standards by revealing a 93% detection rate, from limited detection to the 99th percentile upper reference limit (URL), and maintaining a fluctuation ratio (CV) below 5% at the 99th URL, proving its exceptional effectiveness in identifying myocardial damage. Mindray's NT-proBNP assay is a crucial cardiac marker for heart failure, demonstrating high precision with a coefficient of variation (CV) of =5%. Moreover, it successfully reduces disruption from 55 commonly used heart disease medicines, guaranteeing precise detection and management of heart failure.

What Are the Key Segments of the Cardiac Marker Testing Market?
The cardiac marker testingmarket covered in this report is segmented -

1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:
1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
2) By Instruments: Point-of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report

Which Region Dominates the Cardiac Marker Testing Market?
North America was the largest region in the cardiac marker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Cardiac Marker Testing Global Market Report?

- Market Size Analysis: Analyze the Cardiac Marker Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Cardiac Marker Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Cardiac Marker Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Cardiac Marker Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19358

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.